Last updated: April 23, 2026
What does JP2014111656 cover and how broad are its claims?
JP2014111656 is a Japan patent publication (published in 2014) that contains a family claim set tied to a defined therapeutic and/or composition concept. However, a complete, defensible scope and claim-by-claim analysis requires the actual published claims text (independent and dependent claims) and the prosecution/relationship to any granted member. Those claim texts are not present in the input provided here, and no patent document identifiers (publication number verification, applicant, IPC/CPC, title, or claim excerpts) were supplied.
Because the claim scope is the core of a patent landscape assessment, and because you requested “detailed analysis,” the response cannot be produced accurately without the published claims and the document’s bibliographic record.
What is the claim scope of JP2014111656?
A claim-scope analysis must map, at minimum, each independent claim element (active ingredient(s), composition structure, dosage form, dosing regimen, patient subset, route of administration, use statement, and any functional limitations) and then track how dependent claims narrow those elements.
That requires the exact claim language from JP2014111656:
- Independent claims: element-by-element breakdown
- Dependent claims: what each limitation adds and the resulting narrower embodiments
- Construction risks: terms like “comprising,” Markush language, ranges, and functional features
No claims text was provided, so the scope cannot be reliably enumerated.
How does JP2014111656 position versus competitors in Japan?
A landscape requires:
- Identification of the relevant therapeutic area and mechanism
- Mapping to co-located competitors’ Japan filings (same molecule, same indication, same formulation class)
- Timeline of filings and priority, plus grant/patentability outcomes where available
- Freedom-to-operate relevance: overlaps in claim elements (e.g., specific formulation ratios, salts, polymorphs, dosing windows, or patient subgroups)
Without the patent’s subject matter (from the title/abstract/claims), the competitive mapping cannot be made.
What other jurisdictions are implicated through the family?
For a rigorous family landscape, the standard deliverables include:
- Priority filing and priority date
- Family members (US, EP, WO, CN, KR, etc.) with publication numbers
- Differences in claim scope across jurisdictions
- Early grant signals (where available)
Again, this depends on the published record of JP2014111656, which is not included in the input.
What would an enforceability and risk view look like if the claims were known?
A practical enforceability view normally covers:
- Likely infringement pathways in Japan (composition vs method-of-treatment)
- Claim vulnerabilities (support, clarity, novelty/obviousness risk)
- Expected claim construction levers (range breadth, “comprising” scope, use limitations)
- Patent-term effects in Japan and regulatory linkage considerations (where applicable)
This analysis must be grounded in the actual claim set. No claim text is available here.
Key Takeaways
- A detailed scope-and-claims analysis for JP2014111656 cannot be produced from the information provided.
- Landscape mapping in Japan depends on the actual claim elements, bibliographic record, and subject matter; those are not supplied.
FAQs
-
Can JP2014111656 be analyzed for claim scope without the claims text?
Not for a detailed, element-by-element assessment.
-
Is a Japan-only landscape possible without knowing the therapeutic area and claim elements?
Not in a way that is actionable for R&D or investment.
-
Would the analysis differ if JP2014111656 is a formulation patent vs a method-of-treatment patent?
Yes, because infringement pathways and competitor overlaps differ by claim type.
-
Does family variation across jurisdictions change risk in Japan?
Yes; claim narrowing and amendments can alter the enforceable scope.
-
What inputs are required to produce a complete landscape deliverable?
The published claims (and the bibliographic record) for JP2014111656 and its family links.
References
[1] No sources were provided in the prompt that include the JP2014111656 publication record or its claims text.
